Talquetamab–Daratumumab in Relapsed or Refractory Myeloma - Roberto Mina; Meral Beksac; Paula Rodriguez-Otero; Wenming Chen; María-Victoria Mateos; Jian Li; Philippe Moreau; Yael C. Cohen; Chang-Ki Min; Tomas Jelinek; Jing Christine Ye; Hila Magen; et al. (New England Journal of Medicine, 2026)